The first-and-only fully human monoclonal anti-epidermal growth factor receptor antibody for the treatment of wild-type RAS metastatic colorectal cancer was recently approved by the US Food and Drug...
Researchers at the Cleveland Clinic have developed a new test for diagnosing prostate cancer to improve screening and treatment strategies by better identifying the grade of disease.
Although patients with cancer predominantly prefer oral over intravenous chemotherapy, little research has focused on factors associated with adherence to oral chemotherapy.
Although patients with cancer predominantly prefer oral over intravenous chemotherapy, little research has focused on factors associated with adherence to oral chemotherapy.
Two new studies compared changes in quality of life and the occurrence of adverse events associated with contemporary treatments for localized prostate cancer.